Biofluid Biopsies

Agenda Topics

• Analysis of Somatic Mutations in ctDNA and CTCs
• Circulating Tumor Cells (CTCs): Potential as Prognostic or Predictive Biomarkers
• Circulating Tumor DNA (ctDNA): Potential for Development of Biofluid-based Biopsies
• Emerging Technology Platforms for Interrogating Circulating Biomarkers and Developing Biofluid-based Biopsies
• Biological Fluids such as Blood, Plasma, Serum, Urine, Cerebrospinal Fluid
• Extracellular Nucleic Acids in the Circulating (ctDNA, Circulating Free DNA, Extracellular RNA)
• Enveloped within Extracellular Vesicles (such as Exosomes, Microvesicles, EVs)
• Free in the Circulation

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865

Confirmed Speakers to date

Lyle Arnold, Chief Scientific Officer, Biocept
Martin Beaulieu, Director, Regulus Therapeutics Inc
Farideh Bischoff, Executive Director, Silicon Biosystems Inc
Charles Cantor, Chief Scientific Officer, Sequenom Inc
Dolores Di Vizio, Professor, Cedars Sinai Medical Center
Maximilian Diehn, Assistant Professor, Stanford University School of Medicine
Chris Karlovich, Associate Director, Molecular Diagnostics, Clovis Oncology, Inc.
Shlomit Kenigsberg, Senior Researcher, Create Fertility Centre
Thomas Krahn, Head of Global Biomarker Research Department, Bayer Pharma Ag
Jan Lötvall, Professor, University of Gothenburg; Founding President of ISEV; Editor-in-Chief, Journal of Extracellular Vesicles
Klaus Lücke, CEO & Founder, GILUPI GmbH
Klaus Pantel, Chairman, Department of Tumor Biology, University Medical Center Hamburg-Eppendorf
Jason Poole, Director, Trovagene Inc
Dawne Shelton, Senior Scientist, Bio-Rad Laboratories Digital Biology Center
Pankaj Singhal, Senior Vice President, Corporate Development & Operations, Biomatrica
Edith Szafer-Glusman, Senior Research Associate, Genentech Inc
Jay Therrien, Vice President, Rain Dance Technologies
Kenneth Witwer, Associate Professor, Johns Hopkins University School of Medicine
Theresa Zhang, Vice President, Research Services, Personal Genome Diagnostics

The Two Parallel Conference Tracks Maximize Networking between Pharmaceutical Delegates, Diagnostics Company Delegates, Tools/Technology Vendors, and Academics.

Panel Discussions and Round-Table Breakout Discussions are Included in the Conference Program with Extensive Opportunities for One-on-One Meetings and Networking.

All Conference Delegates, Speakers, and Exhibitors Receive Electronic Copies of Publications and Up-to-Date Reviews on CD.  These Reference Materials are a Valuable Resource to Complement the Conference Presentations, and help with R&D/Business Planning.